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Abstract
Background:  Array-based comparative genomic hybridization (aCGH) is a high-throughput
method for measuring genome-wide DNA copy number changes. Current aCGH methods have
limited resolution, sensitivity and reproducibility. Microarrays for aCGH are available only for a few
organisms and combination of aCGH data with expression data is cumbersome.
Results: We present a novel method of using commercial oligonucleotide expression microarrays
for aCGH, enabling DNA copy number measurements and expression profiles to be combined
using the same platform. This method yields aCGH data from genomic DNA without complexity
reduction at a median resolution of approximately 17,500 base pairs. Due to the well-defined
nature of oligonucleotide probes, DNA amplification and deletion can be defined at the level of
individual genes and can easily be combined with gene expression data.
Conclusion: A novel method of gene resolution analysis of copy number variation (graCNV)
yields high-resolution maps of DNA copy number changes and is applicable to a broad range of
organisms for which commercial oligonucleotide expression microarrays are available. Due to the
standardization of oligonucleotide microarrays, graCNV results can reliably be compared between
laboratories and can easily be combined with gene expression data using the same platform.
Background
Array-based comparative genomic hybridization (aCGH)
allows the identification of genome-wide DNA gains and
losses in cancers and genetic diseases [1-3]. An ideal
aCGH platform should possess the following features: 1)
It should be available to study a broad range of organisms.
Unfortunately, aCGH microarrays are commercially avail-
able for human and mouse studies only, leaving out other
model organisms for DNA copy number studies. 2) The
aCGH platform should be commercially available world-
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wide to make results from different laboratories easily
comparable. In-house microarrays frequently show less
reproducibility than commercial products [4,5]. The
Microarray Quality Control Consortium (MAQC) study
highlighted once again that in-house microarrays generate
a much higher coefficient of variation for expression sig-
nals compared to commercial products [6]. Comparison
of results generated at independent laboratories is fre-
quently problematic when different probes are used at dif-
ferent laboratories. 3) Probes should span short regions to
provide detailed information on regions of copy number
variation (CNV); BAC clones, used as aCGH probes [7],
due to their average probe length being several ten thou-
sand nucleotides, inherently can not measure small
amplified or deleted regions. 4) The platform should pro-
vide small spacing between probes to generate high den-
sity maps of CNVs; The only commercially available BAC
aCGH array available measures at a median resolution of
one megabase [8]. 5) Individual measurements should
provide reliable data to avoid necessity of averaging mul-
tiple measurements, resulting in decreased resolution.
Long oligonucleotide arrays [8,9] and SNP microarrays
[10,11] depend on averaging signals from multiple probes
[9,10] to eliminate false positive measurements, resulting
in decreased resolution. 6) CNV measurements should be
easily correlated with expression data when the same sam-
ples are studied on the genomic and transcriptomic level.
BAC clones and probes designed for SNP measurement
inherently are not specifically designed to interrogate
transcribed genes. Therefore, combining DNA copy
number and expression data needs strong bioinformatics
support [11]. 7) The analytical procedure should interro-
gate the entire genome; the DNA labeling protocol for
SNP microarrays depends on complexity reduction, leav-
ing out significant parts of the genome from analysis
[12,13].
Here we present gene resolution analysis of copy number
variation (graCNV), a method utilizing the most fre-
quently used expression microarray platform for aCGH.
For human and mouse studies, this platform provides
over 50,000 measurements across the genome (U133 Plus
2.0 and 430 2.0 GeneChips respectively, both Affymetrix).
Furthermore, the same technology is available for more
than a dozen other organisms with comparable genome
coverage. The probes are short oligonucleotides and probe
sets span on average short chromosomal regions. Without
complexity reduction, genomic DNA is fragmented,
labeled and hybridized to these microarrays. After re-
annotation of probe sets for interrogation of genomic
DNA, WPP, a data analysis algorithm originally devel-
oped for expression analysis, is utilized for calculation of
DNA copy number variation. Since the vast majority of
aCGH data available today has been generated using BAC
microarrays [14], graCNV results have been compared to
results from BAC microarrays with high genome coverage
[15].
Results
Properties of the U133 Plus 2.0 Expression Array as an 
aCGH tool
The U133 Plus 2.0 array provides over 54,000 probe sets
interrogating the human genome and over 39,000 of the
probe sets measure CNVs directly within transcribed
genes (Table 1). With over 19,000 genes measured on the
U133 Plus 2.0 array, the majority of the predicted 20,000
to 25,000 human genes [16] is covered. Probe sets inter-
rogate short regions and density of probe sets is high. The
19K BAC microarray used for comparison has even higher
genome coverage but probes are much longer (Table 1).
Benefits of the WPP algorithm
RMA, a standard data analysis algorithm for calculation of
expression estimates from Affymetrix GeneChips [17] was
used initially for calculation of DNA copy number differ-
ences. Principle components analysis (PCA) of RMA data
grouped the normal control DNAs together but separated
SK-N-SH/G and SK-N-SH/L (Fig. 1B). These two cell lines
were derived from the same cell line (SK-N-SH) and have
only been propagated by two different laboratories for
approximately ten passages independently. Therefore, SK-
N-SH/G and SK-N-SH/L should be similar to each other
and should cluster together. PCA of WPP estimates
grouped the normal control DNAs together, clearly sepa-
rated from the cell lines and within the cell lines, SK-N-
SH/G and SK-N-SH/L showed most closely related results
(Fig. 1A). Hierarchical clustering of WPP estimates simi-
larly groups related samples together (Fig. 1C), whereas
RMA estimates again separated the two closely related cell
lines SK-N-SH/G and SK-N-SH/L (Fig 1D). Therefore, fur-
ther analysis was performed using WPP estimates of DNA
copy numbers.
Detection of copy number variations in large chromosomal 
regions
For large chromosomal regions, Circular Binary Segmen-
tation (CBS) yields similar pictures of amplification and
deletion in IMR-32 neuroblastoma cells (Fig. 2) from BAC
arrays and expression arrays. Two highly amplified
regions on chromosome 2 (one surrounding the physical
position 15 megabases (Mb) and one surrounding 68
Mb) are well known in neuroblastoma [18]. The ampli-
con at 15 Mb contains the MYCN oncogene and its ampli-
fication status is used for clinical sub-classification of
neuroblastoma [19,20]. Deletions of 1p and 11q, as well
as gains of 17q are also hallmarks of neuroblastoma
[19,20] and all of these copy number variations were
observed in IMR-32 cells by both platforms. The major
differences observed between copy number measure-
ments by BAC arrays and expression arrays affect centro-BMC Genomics 2007, 8:111 http://www.biomedcentral.com/1471-2164/8/111
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meric regions (chromosomes 9, 10, 14, 15 and 21). These
regions are highly polymorphic in normal genomic
DNA[21,22]; therefore, we speculate that these differences
are caused by the different normal control DNAs used for
both platforms. For the remaining cell lines SK-N-AS, SK-
N-SH/G and SK-N-SH/L, BAC aCGH and graCNV also
provided similar pictures of copy number variations for
large chromosomal regions too (Fig. 3 and data not
shown). For SK-N-SH/G and SK-N-SH/L, two sub-cultures
of SK-N-SH, the observed overall picture of copy number
variation compared to normal DNA was very similar
except for an additional amplification on 1q present in
SK-N-SH/L (Fig. 3). This amplification was observed by
both CGH platforms.
High resolution analysis of copy number variations
At higher resolution, BAC aCGH and graCNV again pro-
vide similar pictures of amplifications and deletions in
cancer cell lines. In IMR-32 cells, two recently discovered
sub-amplicons at 67 and 69 Mb of chromosome two [23]
have been identified by CBS in graCNV data, while only
the sub-amplicon at 67 Mb was identified in BAC aCGH
data (Fig. 4A and 4C). In SK-N-SH/G cells, segmentation
identified from graCNV data a deletion of less than one
Mb at 39.5 Mb of chromosome eight (Fig. 4B), which was
not automatically detected in BAC aCGH data (Fig 4D).
graCNV provides information from four independent
probe sets on this deletion. BAC aCGH as used herein,
with more than 50 percent genome coverage provided
information from one BAC clone only. BAC aCGH pro-
vided information on two further amplicons in 2p (one at
29.6 Mb and one at 53.5 Mb) in IMR-32 cells. These
regions are not covered by the U133 Plus 2.0 array (data
not shown).
Detection of copy number variations between normal 
genomic DNAs at a single gene locus
Genomic DNA of normal healthy individuals has been
discovered during the last years to harbor a high number
of copy number variant regions (for review see [24]). As
an example, we show a region on chromosome 6, know to
harbor the well-characterized CNV of the C4/CYP21A2
locus [25]. Normal, healthy individuals with 2, 4, 5 and 6
copies of the C4/CYP21A2 locus have been identified by
pulsed field gel electrophoresis (Fig. 5B). This gene-level
CNV is represented in the graCNV data (Fig. 5C).
Connection of CNV and expression data
graCNV utilizes expression arrays for CNV measurements
and therefore the same microarray can be used for analysis
of gene expression. Genomic and transcriptomic data can
be combined easily. As an example, we show combined
DNA copy number and expression data of the megablad-
der mouse model. An approximately 1 Mb region of chro-
mosome 16 was duplicated in this mouse mutant (Fig.
6E), as identified by FISH analysis. graCNV showed
Il1rap, a gene within the amplicon to be excluded from
higher copy numbers (Fig. 6A), a finding confirmed by
quantitative PCR (Fig. 6B). Expression analysis showed
four of the five amplified genes to be overexpressed in
mutant whole embryos (Fig. 6C), while the bladder (the
affected organ) showed over-expression of three genes
only (Fig. 6D).
Discussion
Our study shows that the most frequently used commer-
cial oligonucleotide expression microarray platform
(Affymetrix) can be utilized for measurement of copy
number variation. After re-annotation of probe sets, these
expression arrays provide a high-resolution platform for
CNV analysis.
Many aCGH platforms depend on averaging measure-
ments from adjacent loci (moving average) to remove
noise and avoid false positive reports of copy number var-
iation [2,9,12,26]. graCNV on the other hand, reports the
bias-corrected median of measurements from eleven adja-
cent probes within a probe set. Therefore, graCNV shows
Table 1: Properties of the U133 Plus 2.0 expression microarray and the 19K BAC microarray as aCGH tools
U133 Plus 2.0 microarray
Total probe sets 54,675 Median length of interrogated regions 535 nucleotides
Probe sets interrogating the human genome 54,045 Mean length of interrogated regions 16,703 nucleotides
Probe sets interrogating intergenic regions 14,735 Median length of regions not covered 17,447 nucleotides
Probe sets interrogating genes 39,310 Mean length of regions not covered 79,884 nucleotides
Interrogated gene regions 17,792
19K BAC microarray
Total probes 19,116 (in duplicates) Median length of interrogated regions 167,632 nucleotides
Probes interrogating the human genome 18,411 (in duplicates) Mean length of interrogated regions 181,473 nucleotides
Median length of regions not covered 2,069 nucleotides
Mean length of regions not covered 31,133 nucleotidesBMC Genomics 2007, 8:111 http://www.biomedcentral.com/1471-2164/8/111
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low false discovery rates (see Additional file 1) and further
averaging is not vital. Affymetrix expression arrays provide
for many genes more than one probe set for measure-
ment. To allow easy interpretation of results, we averaged
results of multiple probe set measuring the same gene. An
even higher resolution of CNV analysis could be accom-
plished when the newly released expression arrays for
measurement of individual exons (GeneChip Human
Exon 1.0 ST arrays, Affymetrix) would be utilized.
For sample labeling, we used standard chemistry for SNP
analysis from the same provider, hybridization and wash-
ing protocols are also well established by many laborato-
ries for SNP analysis. Therefore, it should be easy to adapt
graCNV by other laboratories. Affymetrix currently pro-
The influence of data analysis algorithms on grouping of samples Figure 1
The influence of data analysis algorithms on grouping of samples. Principle components analysis (PCA) and hierarchi-
cal cluster analysis of DNA copy numbers of normal genomic DNAs (C2, C4, C5 and C6) and neuroblastoma cell lines (SK-N-
SH/G, SK-N-SH/L, SK-N-AS and IMR-32). log2 copy number estimates calculated by WPP (left) and RMA (right) were analyzed 
for relative distance by PCA (top) and by hierarchical clustering (bottom). RMA separates two closely related cell lines (SK-N-
SH/G and SK-N-SH/L) in PCA (Fig. 1B) and clustering (Fig. 1D), while WPP groups them together (Fig. 1A and C), clearly sep-
arated from normal genomic DNAs.
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DNA copy number variation in IMR-32 cells measured by graCNV (left) and BAC aCGH (right) Figure 2
DNA copy number variation in IMR-32 cells measured by graCNV (left) and BAC aCGH (right). log2 copy 
number differences relative to normal genomic DNA are shown on a scale from -2 to +2, except for chromosome 2 (-2 to +8). 
log2 copy numbers inferred from CBS are shown as red lines for segments > 1 Mb. Measurements are plotted along the phys-
ical map of chromosomes.BMC Genomics 2007, 8:111 http://www.biomedcentral.com/1471-2164/8/111
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vides expression microarrays for over 20 organisms and
graCNV can be applied to all of these organisms. Addi-
tionally, graCNV provides copy number information
comparable to data generated using one of the highest
density BAC aCGH arrays available.
Hybridization of genomic DNA to expression arrays pro-
duces higher background cross-hybridization (indicated
by relatively high signals for mismatch probes, data not
shown) than hybridization of labeled mRNA transcripts.
We speculate that the reason why the RMA algorithm
failed to identify the close similarity of two cell lines
derived from the same donor was because RMA did not
correct for sequence-specific differences in background.
WPP, the algorithm introduced here for CNV measure-
ments, utilizes mismatch probe signals for sequence-spe-
cific background correction and has been used
successfully for expression analysis by one of our labora-
tories for several years.
Due to the fact that graCNV uses a one chip per sample
principle, the range of CNVs within normal genomic
DNAs can be taken into consideration for measurement of
disease-related CNVs and a free software for this calcula-
tion is provided on our website[27].
A local copy number difference between two closely related cell lines is observed using both aCGH platforms Figure 3
A local copy number difference between two closely related cell lines is observed using both aCGH platforms. 
SK-N-SH/G (red) and SK-N-SH/L (blue), two cell lines derived from the same patient, show copy number differences at 140 to 
228 Mb of chromosome 1, where SK-N-SH/L shows gain while SK-N-SH/G shows normal DNA content. Segmentation analysis 
of BAC aCGH (A) and graCNV (B) highlight the same region as amplified. log2 copy numbers inferred from CBS are shown as 
red (SK-N-SH/G) and blue (SK-N-SH/L) lines.
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Conclusion
The present study describes a novel method of gene reso-
lution analysis of copy number variation (graCNV) yield-
ing high-resolution maps of DNA copy number changes
and applicable to a broad range of organisms for which
commercial oligonucleotide expression microarrays are
available. Results are comparable to BAC aCGH with high
genome coverage. Due to the standardized oligonucle-
otide microarrays, graCNV results can be compared
between laboratories and can easily be combined with
gene expression data using the same platform.
Methods
DNA sources
For analysis of cancer related genomic alterations,
genomic DNA of neuroblastoma cell lines IMR-32, SK-N-
AS and SK-N-SH (all provided by ATCC) was analyzed.
SK-N-SH cells were propagated in two different laborato-
ries for at least ten passages. The resulting cell lines were
analyzed as SK-N-SH/G and SK-N-SH/L. As baseline of
normal human individuals, genomic DNA from periph-
eral blood samples of four females (C2, C4, C5 and C6)
was collected after informed consent. Genomic DNA was
isolated from animals of a mouse strain (megabladder
mouse), which resulted from mutagenesis during generat-
ing transgenic mice. Genetic characterization of the
megabladder mouse using BAC clones containing the
transgene revealed chromosome 16 at approximately 26.4
Mb to be the site of insertional mutation. FISH analysis of
metaphase chromosomes further revealed this region of
chromosome 16 to be translocated into chromosome 11.
Therefore, wild type mice contain two copies of the
genomic region surrounding 26.4 Mb on chromosome
16, heterozygous mutants contained three copies and
homozygous mutants contained four copies. The megab-
ladder mouse will be described in detail elsewhere.
Re-annotation of expression array
Probe sets were aligned to Build 35 version of the human
genome assembly by applying standalone BLAT [28] to
High resolution CNV analysis using BAC aCGH and graCNV provide similar results Figure 4
High resolution CNV analysis using BAC aCGH and graCNV provide similar results. In IMR-32 cells, two ampli-
cons on chromosome 2 at 67 and 69 Mb were inferred by segmentation analysis from graCNV data (C), but only the amplicon 
at 67 Mb from BAC aCGH data (A). In SK-N-SH/G cells, a deletion on chromosome 8 at 39.5 Mb was inferred from graCNV 
data (D), but not from BAC aCGH data (B). Physical positions are shown at the x-axis in units of 1000.
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"concatemers" formed by concatenating the non-overlap-
ping portions of individual 25-mer probe sequences of a
probe set. If BLAT did not report any match for a concate-
mer of a certain probe set, the probe sets was eliminated
from further annotation. Homology of each alignment
was computed as the percentage of concatemer bases
matched and the genomic location with the highest
homology was used for further annotation. The ref-
Flat.txt.gz file[29] contains physical positions of gene
locations according to the human genome assembly ver-
sion Build 35 and has been used for identification of
probe sets interrogating genes. When the genomic loca-
tion with highest homology to a probe set overlapped
with a gene in this database, the probe set was annotated
to measure this particular gene. For multiple probe sets
measuring the same gene, log2 copy number differences
measured by individual probe sets were averaged.
Processing of genomic DNA for graCNV using expression 
arrays
20 μg genomic DNA was digested using EcoRI (New Eng-
land Biolabs). Fragmentation and biotin labeling using
Copy number variations at the C4/CYP21A2 locus in normal, healthy individuals Figure 5
Copy number variations at the C4/CYP21A2 locus in normal, healthy individuals. Schematic map of chromosome 6 
at 32,040 kb to 32,200 kb; the positions interrogated by probe sets are shown by asterisks; the bracket shows the region of 
variable copy numbers (A). Pulsed field electrophoresis analysis of the C4/CYP21A2 region of four individuals showing two 
copies (C2), four copies (C4), five copies (C5) and six copies (C6) of the region. The ruler to the left shows fragment size in 
kb; observed long and short alleles are indicated by L and S respectively (B). graCNV analysis of chromosome 6 at 32,045 kb to 
32,194 kb; log2 copy number differences are shown relative to individual C2 (two copies) for individuals C4 (light gray, four 
copies), C5 (dark gray, five copies) C6 (black, 6 copies).
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Cohesive analysis of DNA copy number changes and differential gene expression in the mouse megabladder model Figure 6
Cohesive analysis of DNA copy number changes and differential gene expression in the mouse megabladder 
model. The region of 25.9 to 28.0 Mb on mouse chromosome 16 contains 10 genes; amplification of five of these genes in 
homozygous mutants of the megabladder mouse was observed by graCNV (A) and confirmed by quantitative PCR (B). Differ-
ential gene expression between homozygous mutants and wild type shows overexpression of four of the amplified genes in 
whole embryos (C) and overexpression of three genes in the target organ, the embryonic bladder (D). (E) Interphase FISH 
analysis of a homozygous megabladder mutant shows two copies of chromosome 11 (green) and four copies of the duplicated 
region of chromosome 16 at 27.0 Mb (red).
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terminal transferase were performed using GeneChip
Mapping 10K Xba Assay Kit (Affymetrix). Human samples
were hybridized to U133plus2.0 GeneChips (Affymetrix)
and mouse samples were hybridized to custom Gene-
Chips containing 4,400 probe sets preferentially measur-
ing genes located on chromosomes 11 and 16
(Affymetrix). Hybridization and other conditions were
slightly modified from those suggested for 10K Mapping
Arrays (Affymetrix) and washing conditions were carried
out as suggested for 100K Mapping Arrays. A detailed
description of sample processing is available in Addi-
tional file 1.
Data analysis for expression arrays
CEL files were generated from scanned images (DAT files)
using GCOS 1.4 software (Affymetrix). Probe set signals
were either generated using the RMA algorithm in Arra-
yAssist 3.4 (Stratagene) or using the in-house developed
WPP algorithm. WPP (Well behaved estimates of differen-
tial gene expression Plus probe-level p-values Plus exten-
sible quantile scaling) software is an enhanced version of
RMA [17]. WPP provides the following advanced analysis
procedures which significantly increase the reliability and
interpretability of calculated differentials: 1) probe-level
nonparametric p-values are used to assess the statistical
significance of individual calculated differentials; 2)
strictly monotonic quantile scaling is used to standardize
PM and MM probe intensity distributions across arrays; 3)
automatic exclusion of uninformative and misinforma-
tive probes is used to increase the accuracy and precision
of calculated differentials. A detailed description of the
WPP algorithm is available in Additional file 1. Measure-
ments of the four normal human DNA samples were used
as baseline for measurement of copy number variation in
the cell lines. CNVs of cell lines were calculated relative to
the median of signals from normal samples.
Principle components analysis and hierarchical cluster 
analysis
Hierarchical cluster analysis in SPSS software was applied
to log2 transformed copy number estimates of probe sets
using a Pearson correlation measure with furthest-neigh-
bor distance. To exclude gender-specific differences, X-
linked and Y-linked genes were excluded. Principle com-
ponents analysis in SPSS software was applied with Var-
imax rotation to log2 transformed copy number estimates
for 2,000 probe sets with the widest range of values for
autosomal chromosomes.
Construction of the Human BAC CGH array
We prepared DNA spotting solutions from sequence con-
nected RPCI-11 BAC by ligation-mediated PCR as
described previously[30]. The array contained ~19,000
BAC clones that were chosen by virtue of their STS con-
tent, end-sequence and association with cancer[15]. Each
clone was spotted in duplicate on amino-silanated glass
slides (Schott Nexterion typeA+) using a MicroGrid ll TAS
arrayer (Apogent Discoveries). The BAC DNA products
have ~80 μm diameter spots with 150 μm center-to-center
spacing creating an array of ~39,000 elements. The
printed slides were dried overnight and thereafter UV-
crosslinked (350 mJ) in a Stratalinker 2400 (Stratagene)
immediately before hybridization. A complete list of the
RPCI-11 BAC clones spotted on the 19k array is available
online[31].
Labeling and Hybridization of DNA for BAC aCGH
One  μg of reference and test sample genomic DNA
(pooled genomic DNA of five individuals) were individu-
ally fluorescently labeled using the BioArray CGH Labe-
ling System (Enzo Life Sciences). Initially, the DNA was
denatured in the presence of the random primer at 99°C
for 10 minutes in a thermalcycler, followed by a quick
chill at 4°C. The tubes were transferred to ice and under-
went labeling with the addition of dNTP-cyanine 3 mix
(or dNTP-cyanine 5) and Klenow. Samples were incu-
bated overnight at 37°C in a thermalcycler. The unincor-
porated nucleotides were removed using a QIAquick PCR
purification column (Qiagen) and the labeled probe is
eluted with 2 × 25 ul washes. Prior to hybridization, the
test and reference probes were resuspended in 110 μl Sli-
deHyb Buffer #3 (Ambion) containing 5 μl of 20 μg/μl
Cot-1 and 5 μl of 100 μg/μl Yeast tRNA (Invitrogen),
heated to 95°C for 5 minutes and placed on ice. Hybridi-
zation to the 19k CGH arrays were performed for 16 hours
at 55°C using a GeneTAC hybridization station (Genomic
Solutions, Inc.) as described[32]. After hybridization, the
slides are automatically washed in the GeneTAC station
with reducing concentrations of SSC and SDS.
Digital Data Acquisition and Analysis for BAC aCGH
The hybridized aCGH slides were scanned using a Gene-
Pix 4200A Scanner (Molecular Devices) to generate high-
resolution (5 μm) images for both Cy3 (test) and Cy5
(control) channels. Image analysis was performed using
the ImaGene (version 6.0.1) software from BioDiscovery,
Inc. A loess corrected log2 ratio of the background-sub-
tracted test/control were calculated for each clone to com-
pensate for non-linear raw aCGH profiles in each sample.
Mapping information was added to the resulting log2 test/
control values. The mapping data for each BAC is found
by querying the human genome sequence[33] and exam-
ined for regions of large scale variation (LSV) in the
human genome[8,26,34,35].
Comparison of copy number segmentation results from 
expression arrays and BAC arrays
Since BAC aCGH microarray and the graCNV microarray
(U133 Plus 2.0 GeneChip) have been annotated accord-
ing to the human genome assembly version 35, coordi-BMC Genomics 2007, 8:111 http://www.biomedcentral.com/1471-2164/8/111
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nates of copy number segments were compared directly.
Copy number segmentation of log2 ratios was performed
in R using the DNAcopy package v1.8.1 which applies
CBS (Circular Binary Segmentation) [36,37], one of the
best available segmentation algorithms [38]. The
undo.splits option was set to "sdundo".
Microarray expression analysis
For expression profiling, 25 ng total RNA per sample was
processed using isothermal amplification SPIA Biotin Sys-
tem (NuGEN Technologies, Inc.) and 2.2 μg of cDNA was
hybridized per microarray. Microarrays utilized were Cus-
tom GeneChips (Affymetrix), containing probe sets to
measure transcripts from mouse chromosomes 11 and 16.
After 16 hours of hybridization at 45°C, washing and
staining of microarrays was performed using a Fluidics
Station 450 (Affymetrix); GeneChips were scanned in a
GeneChip Scanner 3000 (Affymetrix). CEL files were gen-
erated from DAT files using GCOS software (Affymetrix).
All steps of sample and microarray processing were per-
formed according to manufacturer's recommendations.
For calculation of differential gene expression, log2 differ-
ential expression of multiple probe sets per gene were
averaged when more than one probe set was available per
gene.
Quantitative PCR
Tail samples (<1 cm) were snipped from every animal in
the megabladder mouse colony. Tails were digested and
DNA was isolated using Spin Doctor Genomic DNA Isola-
tion kit (Gerard Biotech) according to the manufacturer's
protocol. The DNA was resuspended in resuspension
buffer included in the kit. The concentrations of the sam-
ples were determined by Nanodrop ND1000 spectropho-
tometer (Nanodrop), and the optical density 260/280 nm
ratios were evaluated. Genomic DNA was stored at 4°C
until further use. Mutant mice contain an artificial trans-
gene in addition to the additional copies of the specified
region of chromosome 16. Genotyping of mice by quan-
titative PCR was performed using transgene specific prim-
ers (5'-CAACCGACTCTGCATTCATCTC-3' (forward) and
5'-CTCCAGTACAGCCCTCATGTTTG-3' (reverse) and
probe 5'-6FAM AAGCTTGATATCGAATTC MGBNFQ-3'.
The Glucagon gene was used as internal control with
primers 5'-CACAACATCTCGTGCCAGTCA-3' (forward)
and 5'-ATCTGCATGCAAAGCAATATAGCT-3' (reverse),
and the probe was 5'-VICT GGGATGTACAATTTCAA
MGBNFQ-3'. Working concentrations of primers and
probes were 18 μM and 5 μM, respectively. The multiplex
PCR reactions were set up with 20 ng DNA and TaqMan
Universal PCR Master Mix, No AmpErase UNG (Applied
Biosystems). Reactions were performed in triplicate using
the ABI series 7500 Sequence Detection System (Applied
Biosystems). The initial denaturation was carried out at
50°C for 2 min, followed by 95°C for 10 min (denatura-
tion) followed by 40 cycles of PCR reactions at 95°C for
15 sec and 60°C for 1 min. The amplification data were
further analyzed using ABI 7500 System Sequence Detec-
tion Software Version 1.2.3 (Applied Biosystems). The
genotype was determined by the presence of 0 versus 1
versus 2 copies of the transgene in wild type, heterozygous
and homozygous mice respectively. Copy numbers of
endogenous genes were determined using SYBR Green or
TaqMan chemistry (both from Applied Biosystems). 10 ng
of genomic DNA were used per reaction and amplification
conditions for SYBR Green assays were as follows: 50°C
for 2 min, 95°C for 10 min followed by 40 PCR cycles at
95°C for 15 sec, 54°C for 30 sec and 72°C for 35 sec. The
data was collected at 72°C for 35 sec. TaqMan data for
glucagon were used for normalization. Primers were gen-
erated for the following sequences: 2310061A09Rik (5'
GCCATCTGCATATTCTTTGCTAGCA 3' forward and
5'ACATGGTTTAATGGTAGACTGGGCA 3' reverse); Cldn1
(5'CTCAACCTCCCAACTGTTAAGATGA 3' forward and
5'AACCTCTCCTATAACTGTCAGCTTC 3' reverse); Ostn
(5'GAGTGTTTGCTTCAACTGTGTCAGA 3' forward and
5'AACAAGCCAGGCAGTAACTTCTTTT 3', reverse); Uts2d
(5'GAGTGTTTGCTTCAACTGTGTCAGA 3' forward and 5'
TAGGCTGGTAGAAGTAAACAAGCCA 3' reverse),
2610529H08Rik (5'TGGCGTCTAGGGAACTGAGTTTCTT
3' forward and 5'TGAGGAAACAGCAGTACACGATAAC 3'
reverse), D16Bwg1543e (5'GCTGGCTGCAG-
GGAACAATCTATTT 3' forward and 5'GATGTAGACATAT-
GAGTGGTAGTGA 3' reverse), B230343J05Rik
(5'TGTGATTCATCATCGCTACAGGGAA 3' forward and
5'AACCTTCTCAAAAGCAAGGCCTTGT 3' reverse).
Amplification conditions for TaqMan assays were as
described above for genotyping. Commercial "Primer
probe mixes" (Applied Biosystems) were used for Il1rap
(ILRAP5-K1), Fgf12 (FGF12-1-A2) and Cldn16 (CLDN-
I55S4).
Microarray data are deposited as GEO accession #
GSE7364[39].
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